Eine vollsynthetische Vakzine aus einem tumorassoziierten Glycopeptid-Antigen und einem T-Zell-Epitop zur Induktion einer hochspezifischen humoralen Immunantwort
- 25 November 2005
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 117 (46), 7803-7808
- https://doi.org/10.1002/ange.200501594
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Synthetische Vakzine aus tumorassoziierten MUC1-Glycopeptid-Antigenen und RinderserumalbuminAngewandte Chemie, 2005
- Synthetic Vaccines Consisting of Tumor‐Associated MUC1 Glycopeptide Antigens and Bovine Serum AlbuminAngewandte Chemie, 2005
- The (2‐Phenyl‐2‐trimethylsilyl)ethyl‐(PTMSEL)‐Linker in the Synthesis of Glycopeptide Partial Structures of Complex Cell Surface GlycoproteinsChemistry – A European Journal, 2003
- Sulphotransferases acting on mucin-type oligosaccharidesBiochemical Society Transactions, 2003
- Synthetic Glycopeptides for the Development of Antitumour VaccinesAustralian Journal of Chemistry, 2003
- Glycopeptide-and carbohydratebased synthetic vaccines for the immunotherapy of cancerDrug Discovery Today, 1996
- Peptide Coupling in the Presence of Highly Hindered Tertiary AminesThe Journal of Organic Chemistry, 1996
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994
- Induction by Antigen of Intrathymic Apoptosis of CD4 + CD8 + TCR lo Thymocytes in VivoScience, 1990
- p-Alkoxybenzyl Alcohol Resin and p-Alkoxybenzyloxycarbonylhydrazide Resin for Solid Phase Synthesis of Protected Peptide FragmentsJournal of the American Chemical Society, 1973